The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategiesPeter Bauer, Nobuyuki Nukina|Journal of Neurochemistry|2009Cited by 177
Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson diseaseHelmine Hochstrasser, Daniela Berg, Jens Pahnke et al.|Neurology|2004Cited by 112
Bi-allelic variants in MRPL49 cause variable clinical presentations, including sensorineural hearing loss, leukodystrophy, and ovarian insufficiencyHuw B. Thomas, William G. Newman, Leigh Demain et al.|The American Journal of Human Genetics|2025Cited by 7
The LRRK2 p.L1795F variant causes Parkinson’s disease in the European populationLara M. Lange, Pedro Chaná, Kristin Levine et al.|npj Parkinson s Disease|2025Cited by 3